Sept. 5–6, 2019 • Houston, Texas
View Schedule • Register Now
In the wake of the 2017 U.S. Food and Drug Administration approvals for Chimeric Antigen Receptor (CAR) T cell therapies for the treatment of patients with lymphoma and leukemia, adoptive cellular therapies have rapidly become a focal point for stakeholders across the field of cancer immunotherapy.As this treatment modality has displayed unprecedented patient response and offers significant curative potential for cancer patients across the globe, SITC is proud to host an Adoptive Cellular Therapies Workshop to support both continued momentum and clinical advancement.This two-day workshop will bring together cancer immunotherapy experts to discuss and address challenges concerning the use and development of adoptive cellular therapies for the treatment of cancer patients.Throughout seven didactic sessions and participation in collaborative working groups, attendees will discuss a number of topics, including:
Alessandra Cesano, MD, PhD – NanoString Technologies, Inc.Katayoun Rezvani, MD, PhD– The University of Texas MD Anderson Cancer Center
Royal Sonesta Houston2222 West South LoopHouston, TexasClick below to make your hotel reservation by Wednesday, August 14 to receive a discounted rate. Reserve Your Hotel Room
or to speak to a Reservations Representative, call 1-855-463-3091.
Participants receive a 30 percent discount when registering for both the Cancer Immune Responsiveness and Adoptive Cellular Therapies workshops.Both workshops will help attendees stay at the forefront of new technologies that will impact clinical practice and highlight emerging topics relevant to the immuno-oncology field.Three collaborative sessions, taking place the morning of Sept. 5, will allow attendees from both workshops to discuss commonalities regarding external circumstantial factors, the state of the field, and new concepts that impact cancer immune responsiveness and adoptive cellular therapies.
CIR WORKSHOP SCHEDULE
ACT WORKSHOP SCHEDULE
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org